"Official medicines" is the best online drugstore.

World’s leading meds delivered to your door – and you don’t even need a prescription! Only certified, first class drugs on offer! Buy more and spend less with our great discount system.

The meds you need, reliable and hassle free! Top products of top brands.

The only pharmacy shop you will ever need! Approved drugs available without prescription. Best deals, unmatched service and shipping. 100% safe!


(MILL-rih-nohn LAK-tate)
Primacor
Class: Cardiovascular

 Action Has direct arterial vasodilator activity and positive inotropic effect; ncreases myocardial contractility.

 Indications Short-term treatment of CHF.

 Contraindications Standard considerations.

 Route/Dosage

ADULTS: IV Loading dose: 50 mcg/kg over 10 min; adjust infusion rate according to hemodynamic and clinical response.

 Interactions None well documented. INCOMPATIBILITIES: Precipitate forms if furosemide is injected into same IV line as milrinone; do not administer both in same IV line.

 Lab Test Interferences None well documented.

 Adverse Reactions

CV: Ventricular arrhythmia (eg, ventricular ectopic activity, nonsustained ventricular tachycardia, sustained ventricular tachycardia, ventricular fibrillation); supraventricular arrhythmia; hypotension; angina. CNS: Headaches; tremor. Thrombocytopenia. OTHER: Hypokalemia.

 Precautions

Pregnancy: Category C. Lactation: Undetermined. Children: Safety and efficacy not established. Cardiovascular effects: Do not use in patients with severe obstructive aortic or pulmonic valvular disease; may exacerbate hypertrophic subaortic stenosis; may cause supraventricular and ventricular arrhythmias; may shorten atrioventricular node conduction. Renal impairment: Use drug with caution; monitor renal function. Dosage reduction, based on creatinine clearance, may be needed.

PATIENT CARE CONSIDERATIONS

 Administration/Storage

  • For short-term (up to 5 days) IV use only.
  • Prepare drug for IV infusion by diluting with 0.45% or 0.9% Sodium Chloride Injection D5W.
  • Use infusion pump for administration.
  • Adjust maintenance infusion rate on the basis of hemodynamic and clinical response (maximum rate is 0.75 mcg/kg/min or 1.13 mg/kg/day).
  • Store at room temperature and protect from light.

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Evaluate renal function and identify whether patient has severe obstructive aortic or pulmonic valvular disease.
  • Provide close cardiac and BP monitoring.
  • Be especially observant for supraventricular and ventricular arrhythmias and excessive decreases in BP and report to physician.
  • Carefully monitor fluid and electrolyte changes as well as renal function during therapy.
  • Observe IV site for signs of irritation. Rotate injection site every 48 hr.
  • Correct hypokalemia by potassium supplementation prior to and during use of drug.
  • Observe for other common side effects (headaches, hypokalemia, tremor and thrombocytopenia) and report to physician.
OVERDOSAGE: SIGNS & SYMPTOMS
  Hypotension

 Patient/Family Education

  • Explain what medication does.
  • Inform patient that treatment with this drug usually does not exceed 5 days.
  • Instruct patient to report these symptoms to physician: headache or tremors.

Popularity: 2% [?]


If you're still unable to find appropriate information in the article, please use search form below